- Home
- DTIL vs EDAP Comparison
DTIL vs EDAP Comparison
Compare DTIL & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTIL
- EDAP
- Stock Information
- Founded
- DTIL 2006
- EDAP 1979
- Country
- DTIL United States
- EDAP France
- Employees
- DTIL N/A
- EDAP N/A
- Industry
- DTIL Biotechnology: Pharmaceutical Preparations
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DTIL Health Care
- EDAP Health Care
- Exchange
- DTIL Nasdaq
- EDAP Nasdaq
- Market Cap
- DTIL 51.6M
- EDAP 53.8M
- IPO Year
- DTIL 2019
- EDAP 1997
- Fundamental
- Price
- DTIL $4.49
- EDAP $1.51
- Analyst Decision
- DTIL Strong Buy
- EDAP Buy
- Analyst Count
- DTIL 2
- EDAP 3
- Target Price
- DTIL $47.00
- EDAP $8.50
- AVG Volume (30 Days)
- DTIL 546.0K
- EDAP 36.8K
- Earning Date
- DTIL 07-31-2025
- EDAP 08-27-2025
- Dividend Yield
- DTIL N/A
- EDAP N/A
- EPS Growth
- DTIL N/A
- EDAP N/A
- EPS
- DTIL N/A
- EDAP N/A
- Revenue
- DTIL $51,141,000.00
- EDAP $67,840,467.00
- Revenue This Year
- DTIL N/A
- EDAP N/A
- Revenue Next Year
- DTIL $30.20
- EDAP N/A
- P/E Ratio
- DTIL N/A
- EDAP N/A
- Revenue Growth
- DTIL N/A
- EDAP 3.69
- 52 Week Low
- DTIL $3.61
- EDAP $1.26
- 52 Week High
- DTIL $11.09
- EDAP $5.27
- Technical
- Relative Strength Index (RSI)
- DTIL 54.93
- EDAP 34.23
- Support Level
- DTIL $4.08
- EDAP $1.51
- Resistance Level
- DTIL $4.38
- EDAP $1.63
- Average True Range (ATR)
- DTIL 0.28
- EDAP 0.10
- MACD
- DTIL 0.05
- EDAP -0.01
- Stochastic Oscillator
- DTIL 85.26
- EDAP 3.33
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.